We are live on ! Find out more
NAGE

Niagen Bioscience
NAGE

64 hedge funds and large institutions have $40.9M invested in Niagen Bioscience in 2018 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 20 increasing their positions, 12 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

67% more repeat investments, than reductions

Existing positions increased: 20 | Existing positions reduced: 12

23% more capital invested

Capital invested by funds: $33.2M → $40.9M (+$7.67M)

1.03% more ownership

Funds ownership: 16.3% → 17.33% (+1%)

0% more funds holding

Funds holding: 64 → 64 (0)

0% more first-time investments, than exits

New positions opened: 7 | Existing positions closed: 7

Holders
64
Holders Change
–
Holders Change %
0%
% of All Funds
1.46%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
20
Reduced
12
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Northern Trust
Northern Trust
Illinois
+$1.23M
2
TCM
Tieton Capital Management
Washington
+$741K
3
Vanguard Group
Vanguard Group
Pennsylvania
+$379K
4
State Street
State Street
Massachusetts
+$151K
5
Geode Capital Management
Geode Capital Management
Massachusetts
+$147K

Top Sellers

Rank Fund Capital Flow
1
Wells Fargo
Wells Fargo
California
-$338K
2
GCP
GSA Capital Partners
United Kingdom
-$164K
3
NSIM
North Star Investment Management
Illinois
-$152K
4
Morgan Stanley
Morgan Stanley
New York
-$95.5K
5
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$55K
Name Holding Trade Value Shares
Change 		Change in
Stake
NSIM
26
North Star Investment Management
Illinois
$163K -$152K -35,266 -48%
MML Investors Services
27
MML Investors Services
Massachusetts
$145K +$55.9K +13,000 +63%
RhumbLine Advisers
28
RhumbLine Advisers
Massachusetts
$136K -$1.25K -292 -0.9%
AIG
29
American International Group
New York
$110K +$1.98K +460 +2%
CAN
30
Cetera Advisor Networks
California
$107K – – –
PAG
31
Private Advisor Group
New Jersey
$96K +$95.9K +22,300 New
SBH
32
Segall Bryant & Hamill
Illinois
$94K -$12.9K -3,000 -12%
ARTA
33
A.R.T. Advisors
New York
$93K +$93.6K +21,771 New
Jane Street
34
Jane Street
New York
$90K +$90.5K +21,058 New
VOYA Investment Management
35
VOYA Investment Management
Georgia
$86K – – –
WSTAM
36
Wilbanks Smith & Thomas Asset Management
Virginia
$86K +$86K +20,000 New
Commonwealth Equity Services
37
Commonwealth Equity Services
Massachusetts
$70K +$70.4K +16,367 New
LPL Financial
38
LPL Financial
California
$69K +$1K +233 +1%
New York State Common Retirement Fund
39
New York State Common Retirement Fund
New York
$67K – – –
Barclays
40
Barclays
United Kingdom
$64K +$1.1K +257 +2%
Ameriprise
41
Ameriprise
Minnesota
$64K +$2.15K +500 +3%
GCP
42
GSA Capital Partners
United Kingdom
$59K -$164K -38,200 -74%
CPIG
43
Chicago Partners Investment Group
Illinois
$52K – – –
MCM
44
MAI Capital Management
Ohio
$46K – – –
Citigroup
45
Citigroup
New York
$45K +$21.7K +5,037 +91%
DWM
46
Dynasty Wealth Management
Florida
$44K – – –
Creative Planning
47
Creative Planning
Kansas
$44K +$860 +200 +2%
William Blair & Company
48
William Blair & Company
Illinois
$43K +$43K +10,000 New
JP Morgan Chase
49
JP Morgan Chase
New York
$38K +$4.72K +1,099 +14%
Bank of America
50
Bank of America
North Carolina
$31K +$9.45K +2,198 +43%
1
2
3

NAGE Hedge Fund Activity: Q3 2018 in Review

64 of the 4,375 institutional investors tracked by Wall St. Rank reported a position in Niagen Bioscience (NAGE) for Q3 2018, worth a combined $40.9M — up 23% from $33.2M a quarter earlier.

Fund positioning in NAGE was balanced in Q3 2018: 7 funds opened new positions, 7 closed out, 20 added to existing stakes and 12 trimmed.

The largest buyer was Northern Trust, adding an estimated $1.23M. The largest seller was Wells Fargo, cutting an estimated $338K.

  • 64 institutional investors held Niagen Bioscience (NAGE) as of Q3 2018, unchanged from Q2 2018.
  • Funds reported $40.9M of Niagen Bioscience stock for Q3 2018, up 23% quarter-over-quarter.
  • 7 funds opened new Niagen Bioscience positions in Q3 2018 and 7 closed out, a net change of 0 holders.
  • The largest Niagen Bioscience buyer in Q3 2018 was Northern Trust, an estimated $1.23M added.
  • The largest Niagen Bioscience seller in Q3 2018 was Wells Fargo, an estimated $338K sold.

Based on aggregated 13F filings for Q3 2018.